{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T18:34:45Z","timestamp":1792089285706,"version":"4.4.0"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:00:00Z","timestamp":1778630400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:00:00Z","timestamp":1778630400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Cell Biol"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1038\/s41556-026-01957-1","type":"journal-article","created":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T09:08:18Z","timestamp":1778663298000},"page":"1328-1342","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["High-throughput generation of patient-derived cancer stem cells for precision medicine using a microwell-chip platform"],"prefix":"10.1038","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8648-4162","authenticated-orcid":false,"given":"Zhe","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5621-0857","authenticated-orcid":false,"given":"Jie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-4278-6505","authenticated-orcid":false,"given":"Xuan","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-9302-1264","authenticated-orcid":false,"given":"Mengdie","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-7098-2790","authenticated-orcid":false,"given":"Hanfei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingzhi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinxing","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junjun","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Mei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pan","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanlin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoqin","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7525-4097","authenticated-orcid":false,"given":"Xin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8333-764X","authenticated-orcid":false,"given":"Zhongjuan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0229-763X","authenticated-orcid":false,"given":"Hao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4381-3864","authenticated-orcid":false,"given":"Guangli","family":"Suo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,13]]},"reference":[{"key":"1957_CR1","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.stem.2024.04.004","volume":"31","author":"JJ Loh","year":"2024","unstructured":"Loh, J. J. & Ma, S. Hallmarks of cancer stemness. Cell Stem Cell 31, 617\u2013639 (2024).","journal-title":"Cell Stem Cell"},{"key":"1957_CR2","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1038\/nm.4409","volume":"23","author":"E Batlle","year":"2017","unstructured":"Batlle, E. & Clevers, H. Cancer stem cells revisited. Nat. Med. 23, 1124\u20131134 (2017).","journal-title":"Nat. Med."},{"key":"1957_CR3","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/s41392-024-01851-y","volume":"9","author":"X Chu","year":"2024","unstructured":"Chu, X. et al. Cancer stem cells: advances in knowledge and implications for cancer therapy. Signal Transduct. Target. Ther. 9, 170 (2024).","journal-title":"Signal Transduct. Target. Ther."},{"key":"1957_CR4","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1158\/2159-8290.CD-18-0349","volume":"8","author":"H Tiriac","year":"2018","unstructured":"Tiriac, H. et al. Organoid profiling identifies common responders to chemotherapy in pancreatic cancer. Cancer Discov. 8, 1112\u20131129 (2018).","journal-title":"Cancer Discov."},{"key":"1957_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.217108","volume":"599","author":"K Vojnits","year":"2024","unstructured":"Vojnits, K. et al. Targeting of human cancer stem cells predicts efficacy and toxicity of FDA-approved oncology drugs. Cancer Lett. 599, 217108 (2024).","journal-title":"Cancer Lett."},{"key":"1957_CR6","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/s41392-020-0110-5","volume":"5","author":"L Yang","year":"2020","unstructured":"Yang, L. et al. Targeting cancer stem cell pathways for cancer therapy. Signal Transduct. Target. Ther. 5, 8 (2020).","journal-title":"Signal Transduct. Target. Ther."},{"key":"1957_CR7","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1002\/cyto.a.23740","volume":"95","author":"A Tarnok","year":"2019","unstructured":"Tarnok, A. Cancer and cytometry. Cytometry A 95, 257\u2013258 (2019).","journal-title":"Cytometry A"},{"key":"1957_CR8","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1158\/0008-5472.CAN-22-2053","volume":"83","author":"L Lan","year":"2023","unstructured":"Lan, L. & Behrens, A. Are there specific cancer stem cell markers?. Cancer Res. 83, 170\u2013172 (2023).","journal-title":"Cancer Res."},{"key":"1957_CR9","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1126\/science.1553558","volume":"255","author":"BA Reynolds","year":"1992","unstructured":"Reynolds, B. A. & Weiss, S. Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system. Science 255, 1707\u20131710 (1992).","journal-title":"Science"},{"key":"1957_CR10","doi-asserted-by":"publisher","first-page":"e325","DOI":"10.21769\/BioProtoc.325","volume":"3","author":"S Johnson","year":"2013","unstructured":"Johnson, S., Chen, H. & Lo, P. K. In vitro tumorsphere formation assays. Bio Protoc. 3, e325 (2013).","journal-title":"Bio Protoc."},{"key":"1957_CR11","doi-asserted-by":"publisher","first-page":"6863","DOI":"10.1158\/0008-5472.CAN-08-2852","volume":"68","author":"LA Loeb","year":"2008","unstructured":"Loeb, L. A. & Harris, C. C. Advances in chemical carcinogenesis: a historical review and prospective. Cancer Res. 68, 6863\u20136872 (2008).","journal-title":"Cancer Res."},{"key":"1957_CR12","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.cell.2010.01.025","volume":"140","author":"SI Grivennikov","year":"2010","unstructured":"Grivennikov, S. I., Greten, F. R. & Karin, M. Immunity, inflammation, and cancer. Cell 140, 883\u2013899 (2010).","journal-title":"Cell"},{"key":"1957_CR13","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1111\/nyas.12811","volume":"1348","author":"IA Siddiqui","year":"2015","unstructured":"Siddiqui, I. A., Sanna, V., Ahmad, N., Sechi, M. & Mukhtar, H. Resveratrol nanoformulation for cancer prevention and therapy. Ann. N. Y. Acad. Sci. 1348, 20\u201331 (2015).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"1957_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-017-0602-2","volume":"16","author":"K Qureshi-Baig","year":"2017","unstructured":"Qureshi-Baig, K., Ullmann, P., Haan, S. & Letellier, E. Tumor-initiating cells: a criTICal review of isolation approaches and new challenges in targeting strategies. Mol. Cancer 16, 40 (2017).","journal-title":"Mol. Cancer"},{"key":"1957_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neo.2014.12.004","volume":"17","author":"LB Weiswald","year":"2015","unstructured":"Weiswald, L. B., Bellet, D. & Dangles-Marie, V. Spherical cancer models in tumor biology. Neoplasia 17, 1\u201315 (2015).","journal-title":"Neoplasia"},{"key":"1957_CR16","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.canlet.2014.01.012","volume":"346","author":"Y Li","year":"2014","unstructured":"Li, Y. & Zhang, T. Targeting cancer stem cells by curcumin and clinical applications. Cancer Lett. 346, 197\u2013205 (2014).","journal-title":"Cancer Lett."},{"key":"1957_CR17","doi-asserted-by":"publisher","first-page":"e77281","DOI":"10.1371\/journal.pone.0077281","volume":"8","author":"J Manuel Iglesias","year":"2013","unstructured":"Manuel Iglesias, J. et al. Mammosphere formation in breast carcinoma cell lines depends upon expression of E-cadherin. PLoS ONE 8, e77281 (2013).","journal-title":"PLoS ONE"},{"key":"1957_CR18","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.stem.2007.08.014","volume":"1","author":"C Ginestier","year":"2007","unstructured":"Ginestier, C. et al. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell 1, 555\u2013567 (2007).","journal-title":"Cell Stem Cell"},{"key":"1957_CR19","doi-asserted-by":"publisher","first-page":"4234","DOI":"10.1158\/1078-0432.CCR-08-1479","volume":"15","author":"T Tanei","year":"2009","unstructured":"Tanei, T. et al. Association of breast cancer stem cells identified by aldehyde dehydrogenase 1 expression with resistance to sequential Paclitaxel and epirubicin-based chemotherapy for breast cancers. Clin. Cancer Res. 15, 4234\u20134241 (2009).","journal-title":"Clin. Cancer Res."},{"key":"1957_CR20","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1002\/cyto.a.23507","volume":"93","author":"Y Lee","year":"2018","unstructured":"Lee, Y., Guan, G. & Bhagat, A. A. ClearCell(R) FX, a label-free microfluidics technology for enrichment of viable circulating tumor cells. Cytometry A 93, 1251\u20131254 (2018).","journal-title":"Cytometry A"},{"key":"1957_CR21","doi-asserted-by":"publisher","first-page":"4418","DOI":"10.1039\/D2LC00713D","volume":"22","author":"K Shirai","year":"2022","unstructured":"Shirai, K. et al. Hybrid double-spiral microfluidic chip for RBC-lysis-free enrichment of rare cells from whole blood. Lab Chip 22, 4418\u20134429 (2022).","journal-title":"Lab Chip"},{"key":"1957_CR22","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1007\/978-1-0716-1979-7_38","volume":"2429","author":"P den Hollander","year":"2022","unstructured":"den Hollander, P. et al. Limiting dilution tumor initiation assay: an in vivo approach for the study of cancer stem cells. Methods Mol. Biol. 2429, 547\u2013554 (2022).","journal-title":"Methods Mol. Biol."},{"key":"1957_CR23","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1016\/j.cell.2020.07.039","volume":"182","author":"F Bonnay","year":"2020","unstructured":"Bonnay, F. et al. Oxidative metabolism drives immortalization of neural stem cells during tumorigenesis. Cell 182, 1490\u20131507 (2020).","journal-title":"Cell"},{"key":"1957_CR24","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1126\/science.aao2774","volume":"359","author":"G Vlachogiannis","year":"2018","unstructured":"Vlachogiannis, G. et al. Patient-derived organoids model treatment response of metastatic gastrointestinal cancers. Science 359, 920\u2013926 (2018).","journal-title":"Science"},{"key":"1957_CR25","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.cell.2014.08.016","volume":"159","author":"D Gao","year":"2014","unstructured":"Gao, D. et al. Organoid cultures derived from patients with advanced prostate cancer. Cell 159, 176\u2013187 (2014).","journal-title":"Cell"},{"key":"1957_CR26","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.stem.2019.10.010","volume":"26","author":"Y Yao","year":"2020","unstructured":"Yao, Y. et al. Patient-derived organoids predict chemoradiation responses of locally advanced rectal cancer. Cell Stem Cell 26, 17\u201326 (2020).","journal-title":"Cell Stem Cell"},{"key":"1957_CR27","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202101176","volume":"8","author":"P Chen","year":"2021","unstructured":"Chen, P. et al. Patient-derived organoids can guide personalized-therapies for patients with advanced breast cancer. Adv. Sci. 8, e2101176 (2021).","journal-title":"Adv. Sci."},{"key":"1957_CR28","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1038\/nm.4438","volume":"23","author":"L Broutier","year":"2017","unstructured":"Broutier, L. et al. Human primary liver cancer-derived organoid cultures for disease modeling and drug screening. Nat. Med. 23, 1424\u20131435 (2017).","journal-title":"Nat. Med."},{"key":"1957_CR29","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.cell.2019.11.036","volume":"180","author":"F Jacob","year":"2020","unstructured":"Jacob, F. et al. A patient-derived glioblastoma organoid model and biobank recapitulates inter- and intra-tumoral heterogeneity. Cell 180, 188\u2013204.e22 (2020).","journal-title":"Cell"},{"key":"1957_CR30","doi-asserted-by":"crossref","unstructured":"Yin, S. et al. Patient-derived tumor-like cell clusters for drug testing in cancer therapy. Sci. Transl. Med. 12, (2020).","DOI":"10.1126\/scitranslmed.aaz1723"},{"key":"1957_CR31","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1200\/JCO.21.02054","volume":"40","author":"H Joensuu","year":"2022","unstructured":"Joensuu, H. et al. Adjuvant capecitabine for early breast cancer: 15-year overall survival results from a randomized trial. J. Clin. Oncol. 40, 1051\u20131058 (2022).","journal-title":"J. Clin. Oncol."},{"key":"1957_CR32","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.cell.2009.12.007","volume":"140","author":"S Pece","year":"2010","unstructured":"Pece, S. et al. Biological and molecular heterogeneity of breast cancers correlates with their cancer stem cell content. Cell 140, 62\u201373 (2010).","journal-title":"Cell"},{"key":"1957_CR33","doi-asserted-by":"publisher","first-page":"3337","DOI":"10.1158\/0008-5472.CAN-24-0030","volume":"84","author":"GG Bushnell","year":"2024","unstructured":"Bushnell, G. G. et al. Natural killer cell regulation of breast cancer stem cells mediates metastatic dormancy. Cancer Res. 84, 3337\u20133353 (2024).","journal-title":"Cancer Res."},{"key":"1957_CR34","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/s41563-021-01057-5","volume":"21","author":"BL LeSavage","year":"2022","unstructured":"LeSavage, B. L., Suhar, R. A., Broguiere, N., Lutolf, M. P. & Heilshorn, S. C. Next-generation cancer organoids. Nat. Mater. 21, 143\u2013159 (2022).","journal-title":"Nat. Mater."},{"key":"1957_CR35","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1016\/j.it.2020.06.010","volume":"41","author":"K Yuki","year":"2020","unstructured":"Yuki, K., Cheng, N., Nakano, M. & Kuo, C. J. Organoid models of tumor immunology. Trends Immunol. 41, 652\u2013664 (2020).","journal-title":"Trends Immunol."},{"key":"1957_CR36","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/j.stem.2022.04.006","volume":"29","author":"S Ding","year":"2022","unstructured":"Ding, S. et al. Patient-derived micro-organospheres enable clinical precision oncology. Cell Stem Cell 29, 905\u2013917 (2022).","journal-title":"Cell Stem Cell"},{"key":"1957_CR37","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/j.stem.2020.07.003","volume":"27","author":"P Cheung","year":"2020","unstructured":"Cheung, P. et al. Regenerative reprogramming of the intestinal stem cell state via Hippo signaling suppresses metastatic colorectal cancer. Cell Stem Cell 27, 590\u2013604 (2020).","journal-title":"Cell Stem Cell"},{"key":"1957_CR38","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1016\/j.stem.2021.03.005","volume":"28","author":"M Breunig","year":"2021","unstructured":"Breunig, M. et al. Modeling plasticity and dysplasia of pancreatic ductal organoids derived from human pluripotent stem cells. Cell Stem Cell 28, 1105\u20131124 (2021).","journal-title":"Cell Stem Cell"},{"key":"1957_CR39","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1016\/j.stem.2023.05.012","volume":"30","author":"HHN Yan","year":"2023","unstructured":"Yan, H. H. N., Chan, A. S., Lai, F. P. & Leung, S. Y. Organoid cultures for cancer modeling. Cell Stem Cell 30, 917\u2013937 (2023).","journal-title":"Cell Stem Cell"},{"key":"1957_CR40","doi-asserted-by":"publisher","first-page":"762184","DOI":"10.3389\/fonc.2021.762184","volume":"11","author":"Z Zhou","year":"2021","unstructured":"Zhou, Z., Cong, L. & Cong, X. Patient-derived organoids in precision medicine: drug screening, organoid-on-a-chip and living organoid biobank. Front. Oncol. 11, 762184 (2021).","journal-title":"Front. Oncol."},{"key":"1957_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.107588","volume":"31","author":"KK Dijkstra","year":"2020","unstructured":"Dijkstra, K. K. et al. Challenges in establishing pure lung cancer organoids limit their utility for personalized medicine. Cell Rep. 31, 107588 (2020).","journal-title":"Cell Rep."},{"key":"1957_CR42","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/nprot.2016.006","volume":"11","author":"J Drost","year":"2016","unstructured":"Drost, J. et al. Organoid culture systems for prostate epithelial and cancer tissue. Nat. Protoc. 11, 347\u2013358 (2016).","journal-title":"Nat. Protoc."},{"key":"1957_CR43","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/j.cell.2015.03.053","volume":"161","author":"M van de Wetering","year":"2015","unstructured":"van de Wetering, M. et al. Prospective derivation of a living organoid biobank of colorectal cancer patients. Cell 161, 933\u2013945 (2015).","journal-title":"Cell"},{"key":"1957_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/srep27301","volume":"6","author":"YC Chen","year":"2016","unstructured":"Chen, Y. C. et al. High-throughput single-cell derived sphere formation for cancer stem-like cell identification and analysis. Sci. Rep. 6, 27301 (2016).","journal-title":"Sci. Rep."},{"key":"1957_CR45","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/s41576-018-0051-9","volume":"19","author":"G Rossi","year":"2018","unstructured":"Rossi, G., Manfrin, A. & Lutolf, M. P. Progress and potential in organoid research. Nat. Rev. Genet. 19, 671\u2013687 (2018).","journal-title":"Nat. Rev. Genet."},{"key":"1957_CR46","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/j.stem.2024.03.008","volume":"31","author":"S Yin","year":"2024","unstructured":"Yin, S. et al. Patient-derived tumor-like cell clusters for personalized chemo- and immunotherapies in non-small cell lung cancer. Cell Stem Cell 31, 717\u2013733 (2024).","journal-title":"Cell Stem Cell"},{"key":"1957_CR47","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s13045-019-0738-1","volume":"12","author":"P Zhao","year":"2019","unstructured":"Zhao, P., Li, L., Jiang, X. & Li, Q. Mismatch repair deficiency\/microsatellite instability-high as a predictor for anti-PD-1\/PD-L1 immunotherapy efficacy. J. Hematol. Oncol. 12, 54 (2019).","journal-title":"J. Hematol. Oncol."},{"key":"1957_CR48","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/j.ccell.2020.08.005","volume":"38","author":"CS Grasso","year":"2020","unstructured":"Grasso, C. S. et al. Conserved interferon-gamma signaling drives clinical response to immune checkpoint blockade therapy in melanoma. Cancer Cell 38, 500\u2013515 (2020).","journal-title":"Cancer Cell"},{"key":"1957_CR49","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1200\/JCO.2017.76.9901","volume":"36","author":"MJ Overman","year":"2018","unstructured":"Overman, M. J. et al. Durable clinical benefit with nivolumab plus ipilimumab in DNA mismatch repair-deficient\/microsatellite instability-high metastatic colorectal cancer. J. Clin. Oncol. 36, 773\u2013779 (2018).","journal-title":"J. Clin. Oncol."},{"key":"1957_CR50","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1056\/NEJMoa1801005","volume":"378","author":"L Gandhi","year":"2018","unstructured":"Gandhi, L. et al. Pembrolizumab plus chemotherapy in metastatic non-small-cell lung cancer. N. Engl. J. Med. 378, 2078\u20132092 (2018).","journal-title":"N. Engl. J. Med."},{"key":"1957_CR51","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1126\/science.aaf2834","volume":"352","author":"CU Blank","year":"2016","unstructured":"Blank, C. U., Haanen, J. B., Ribas, A. & Schumacher, T. N. Cancer immunology. The \u2018cancer immunogram\u2019. Science 352, 658\u2013660 (2016).","journal-title":"Science"},{"key":"1957_CR52","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.cell.2017.01.017","volume":"168","author":"P Sharma","year":"2017","unstructured":"Sharma, P., Hu-Lieskovan, S., Wargo, J. A. & Ribas, A. Primary, adaptive, and acquired resistance to cancer immunotherapy. Cell 168, 707\u2013723 (2017).","journal-title":"Cell"},{"key":"1957_CR53","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1038\/nrclinonc.2017.44","volume":"14","author":"T Shibue","year":"2017","unstructured":"Shibue, T. & Weinberg, R. A. EMT, CSCs, and drug resistance: the mechanistic link and clinical implications. Nat. Rev. Clin. Oncol. 14, 611\u2013629 (2017).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"1957_CR54","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1038\/s41418-021-00878-w","volume":"29","author":"T Velletri","year":"2022","unstructured":"Velletri, T. et al. Single cell-derived spheroids capture the self-renewing subpopulations of metastatic ovarian cancer. Cell Death Differ. 29, 614\u2013626 (2022).","journal-title":"Cell Death Differ."},{"key":"1957_CR55","doi-asserted-by":"publisher","first-page":"3801","DOI":"10.21873\/anticanres.14369","volume":"40","author":"JM Cho","year":"2020","unstructured":"Cho, J. M. et al. Papillary thyroid cancer tumor spheres cultured by passaging without sorting exhibit cancer stemness. Anticancer Res. 40, 3801\u20133809 (2020).","journal-title":"Anticancer Res."},{"key":"1957_CR56","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1038\/s41551-020-0565-2","volume":"4","author":"N Brandenberg","year":"2020","unstructured":"Brandenberg, N. et al. High-throughput automated organoid culture via stem-cell aggregation in microcavity arrays. Nat. Biomed. Eng. 4, 863\u2013874 (2020).","journal-title":"Nat. Biomed. Eng."},{"key":"1957_CR57","doi-asserted-by":"publisher","unstructured":"Zhao, Z. Fabrication of alginic acid sodium salt -based MWC-chip. protocols.io https:\/\/doi.org\/10.17504\/protocols.io.dm6gp12w1gzp\/v1 (2026).","DOI":"10.17504\/protocols.io.dm6gp12w1gzp\/v1"},{"key":"1957_CR58","doi-asserted-by":"publisher","unstructured":"Zhao, Z. X., Xuan, X., Mengdie, Y. & Guangli, S. MTSs generation, characterization, collection and passage. protocols.io https:\/\/doi.org\/10.17504\/protocols.io.n2bvj1jxwvk5\/v2 (2026).","DOI":"10.17504\/protocols.io.n2bvj1jxwvk5\/v2"},{"key":"1957_CR59","doi-asserted-by":"publisher","first-page":"1936","DOI":"10.1038\/s41596-020-00474-1","volume":"16","author":"JF Dekkers","year":"2021","unstructured":"Dekkers, J. F. et al. Long-term culture, genetic manipulation and xenotransplantation of human normal and breast cancer organoids. Nat. Protoc. 16, 1936\u20131965 (2021).","journal-title":"Nat. Protoc."},{"key":"1957_CR60","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1038\/nprot.2015.088","volume":"10","author":"M Fujii","year":"2015","unstructured":"Fujii, M., Matano, M., Nanki, K. & Sato, T. Efficient genetic engineering of human intestinal organoids using electroporation. Nat. Protoc. 10, 1474\u20131485 (2015).","journal-title":"Nat. Protoc."},{"key":"1957_CR61","doi-asserted-by":"publisher","unstructured":"Zhao, Z., G. S., Xiong, X., Yang, M. & Wu, H. The establishment of tumor model in vivo. protocols.io https:\/\/doi.org\/10.17504\/protocols.io.4r3l2zb4xl1y\/v1 (2026).","DOI":"10.17504\/protocols.io.4r3l2zb4xl1y\/v1"},{"key":"1957_CR62","doi-asserted-by":"publisher","unstructured":"Zhao, Z., G. S., Xiong, X. & Yang, M. Whole exome sequencing (WES), mutation and copy number analysis and single-cell RNA-seq (scRNA-seq). protocols.io https:\/\/doi.org\/10.17504\/protocols.io.36wgq1y4xvk5\/v1 (2026).","DOI":"10.17504\/protocols.io.36wgq1y4xvk5\/v1"},{"key":"1957_CR63","doi-asserted-by":"publisher","unstructured":"Guangli, S. & Z. Z. Determination of the cutoff value for drug efficacy in MTSs model. protocols.io https:\/\/doi.org\/10.17504\/protocols.io.x54v9bzyml3e\/v1 (2026).","DOI":"10.17504\/protocols.io.x54v9bzyml3e\/v1"},{"key":"1957_CR64","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1016\/j.xphs.2021.12.021","volume":"111","author":"S Sakai","year":"2022","unstructured":"Sakai, S., Kobuchi, S., Ito, Y. & Sakaeda, T. Assessment of drug\u2013drug interaction and optimization in capecitabine and irinotecan combination regimen using a physiologically based pharmacokinetic model. J. Pharm. Sci. 111, 1522\u20131530 (2022).","journal-title":"J. Pharm. Sci."},{"key":"1957_CR65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.tiv.2017.10.005","volume":"46","author":"Z Li","year":"2018","unstructured":"Li, Z. et al. Assessment of hepatic metabolism-dependent nephrotoxicity on an organs-on-a-chip microdevice. Toxicol. In Vitro 46, 1\u20138 (2018).","journal-title":"Toxicol. In Vitro"},{"key":"1957_CR66","doi-asserted-by":"publisher","unstructured":"Zhao, Z., X. X., Wu, H., Xu, Z. & Suo, G. The examination of BRC markers expression and the target sequence amplification for single MTSs. protocols.io https:\/\/doi.org\/10.17504\/protocols.io.q26g77643gwz\/v1 (2026).","DOI":"10.17504\/protocols.io.q26g77643gwz\/v1"},{"key":"1957_CR67","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.cell.2017.11.010","volume":"172","author":"N Sachs","year":"2018","unstructured":"Sachs, N. et al. A living biobank of breast cancer organoids captures disease heterogeneity. Cell 172, 373\u2013386 (2018).","journal-title":"Cell"},{"key":"1957_CR68","doi-asserted-by":"publisher","unstructured":"Guangli, S., Z. Z., Yang, M. & Xiong, X. The establishment of an in vitro immunotherapy model based on MTSs. protocols.io https:\/\/doi.org\/10.17504\/protocols.io.ewov1kxnygr2\/v1 (2026).","DOI":"10.17504\/protocols.io.ewov1kxnygr2\/v1"},{"key":"1957_CR69","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/s41556-025-01832-5","volume":"28","author":"BH Lee","year":"2026","unstructured":"Lee, B. H. et al. Permeability-driven pressure and cell proliferation control lumen morphogenesis in pancreatic organoids. Nat. Cell Biol. 28, 113\u2013124 (2026).","journal-title":"Nat. Cell Biol."}],"container-title":["Nature Cell Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41556-026-01957-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41556-026-01957-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41556-026-01957-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T21:02:23Z","timestamp":1781816543000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41556-026-01957-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,13]]},"references-count":69,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["1957"],"URL":"https:\/\/doi.org\/10.1038\/s41556-026-01957-1","relation":{},"ISSN":["1465-7392","1476-4679"],"issn-type":[{"value":"1465-7392","type":"print"},{"value":"1476-4679","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,13]]},"assertion":[{"value":"1 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}